Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT06494059 · ClinicalTrials.gov registry record · NA

A Novel Repetitive Synchronized Associative Stimulation Neuromodulation Approach for Spinal Cord Injury Patients

A NA study of SCI - Spinal Cord Injury, sponsored by University of Miami.

Recruiting
Registry status
NA
Development phase
25
Enrollment target
1
Study location

NCT06494059: Recruiting NA study of SCI - Spinal Cord Injury, sponsored by University of Miami.

NCT06494059 is a NA study of SCI - Spinal Cord Injury that is actively recruiting participants, run by University of Miami. The registered enrollment target is 25 participants, below the 36-participant average among 13 other SCI - Spinal Cord Injury trials with a reported enrollment target (31% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT06494059, a NA study of SCI - Spinal Cord Injury, is actively recruiting participants, sponsored by University of Miami.

RECRUITING
Registry status
NA
Development phase
25 participants
Enrollment target
1
Study location

Study Summary

The purpose of this research is to explore the effect of magnetic stimulation to activate the brain, electrical spinal cord stimulation to activate spinal cord, and electrical muscle stimulation used to activate upper limb (arms), lower limb (legs) and trunk (stomach) muscles in people with spinal cord injury (SCI) and able-bodied subjects (without SCI).

Primary Outcome

The Nine-Hole Peg Test assesses hand and finger dexterity. It is administered by asking the subject to take the pegs from a container, one by one, and place them into holes on the board as quickly as possible. Participants must then remove the pegs from the holes, one by one, and replace them back into the container. Scores are based on the time taken to complete the activity, recorded in seconds.

Conditions Studied

Interventions

  • OTHER Intermittent theta burst stimulation (iTBS)
  • OTHER Functional electrical stimulation (FES)
  • OTHER Transcutaneous spinal cord stimulation (TSCS)
  • OTHER Sham Intermittent theta burst stimulation (iTBS)

Study Locations (1)

Florida

  • University of Miami - Miami

Trial Details

FieldValue
Enrollment Target 25 participants
Start Date 2024-11-04
Est. Completion 2026-12-30
Phase NA
University of Miami

721 total trials

What NCT06494059 shows while recruiting

NCT06494059 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 25 participants, a relatively small participant target, below the 36-participant average among 13 other SCI - Spinal Cord Injury trials with a reported enrollment target (31% lower).

The record links to 1 condition, with SCI - Spinal Cord Injury appearing as the primary indexed condition, and to 4 interventions - of which Intermittent theta burst stimulation (iTBS) is the first listed.

NCT06494059 reports a single indexed study location in Florida.

Frequently Asked Questions

What is clinical trial NCT06494059 about?

NCT06494059 is a clinical study titled "A Novel Repetitive Synchronized Associative Stimulation Neuromodulation Approach for Spinal Cord Injury Patients". The purpose of this research is to explore the effect of magnetic stimulation to activate the brain, electrical spinal cord stimulation to activate spinal cord, and electrical muscle stimulation used to activate upper limb (arms), lower limb (legs) and trunk (stomach) muscles in people with spinal c...

What is the current status of trial NCT06494059?

This trial is currently recruiting. It is a NA study. The enrollment target is 25 participants. The study started on 2024-11-04. Estimated completion is 2026-12-30.

What conditions does trial NCT06494059 study?

This clinical trial studies the following conditions: SCI - Spinal Cord Injury.

What interventions are being tested in trial NCT06494059?

The interventions under investigation include: Intermittent theta burst stimulation (iTBS) (OTHER), Functional electrical stimulation (FES) (OTHER), Transcutaneous spinal cord stimulation (TSCS) (OTHER), Sham Intermittent theta burst stimulation (iTBS) (OTHER).

Who is sponsoring clinical trial NCT06494059?

This trial is sponsored by University of Miami, which has 721 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT06494059 being conducted?

This trial has 1 study location across Florida. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for SCI - Spinal Cord Injury

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Where NCT06494059's enrollment target sits among peer trials

25 9th of 13 higher than 5 of 13 other SCI - Spinal Cord Injury trials

participants (enrollment target), bucketed by value

Each bar is a band; taller bars hold more other SCI - Spinal Cord Injury trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.

Source ClinicalTrials.gov registry export · 2026-08-08

Nationwide trials with similar profiles

Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.

Similar enrollment target

  • NCT01166854 · 25 participants

    Characterization of Familial Myopathy and Paget Disease of Bone

  • NCT01913106 · 25 participants · Phase 1

    HSV-tk + Valacyclovir Therapy in Combination With Brachytherapy for Recurrent Prostate Cancer

  • NCT02138669 · 25 participants · NA

    Intacs Prescription Inserts for Keratoconus Patients

  • NCT02174549 · 25 participants · Phase 1

    Dose-defining Study of Tirapazamine Combined With Embolization in Liver Cancer

Similar registry start date

  • NCT05962346 · started 2026-12 · NA

    Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia

  • NCT07125183 · started 2026-12 · Phase 2

    Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma

  • NCT07292298 · started 2026-11 · Phase 2

    Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates

  • NCT04263285 · started 2026-10 · NA

    Treatment of Depression Post-SCI

Source: ClinicalTrials.gov NCT06494059, the US trial registry maintained by the National Library of Medicine. NCT06494059 (small enrollment · single site footprint · recruiting) retrieved and formatted by PlainTrial, see methodology.